Stride Therapeutics
Investment
area
Venture Investments
Region
North America
Date of
investment
April 2021
StrideBio is a product-driven, fully integrated gene therapy company focused on creating and developing innovative genetic medicines with life-changing or curative potential for patients with devastating conditions, including monogenic rare disease and beyond.